Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical Countermeasures Medical Countermeasures March 18, 2025 …
Acurx Announces Anthrax Susceptibility to ACX-375 Analogues Medical Countermeasures September 26, 2024 …
First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test Biodetection December 5, 2023 …
BARDA-Supported Anthrax Vaccine Now Approved, Enables Faster Onset to Protection Industry News August 7, 2023 …
Elusys Therapeutics Finalizes HHS Contract to Deliver Inhalation Anthrax Treatment Medical Countermeasures January 31, 2022 …
Stopping Lethal Anthrax Using an Enzyme to Disrupt the Bacterial Capsule Defense + Military December 8, 2021 …
Penn State Researchers Will Map 700 of Anthrax Bacteria’s Closest Relatives Research October 27, 2021 …
LexaGene Enters into CRADA with DoD to Foster Biothreat Detection Capabilities Biodetection September 23, 2021 …
NBACC: Past Bioagent Research Informs Current and Future Pandemic Response Biosecurity March 19, 2021 …
Decontamination of Bacillus Spores from Drinking Water Infrastructure Decontamination September 21, 2019 …
BARDA Exercises First Option in Transition from BioThrax to AV7909 Anthrax Vaccine Contracts + Grants August 1, 2019 …
Researchers Optimize Novel Hexaplex PCR Assay for Simultaneous Detection of Anthrax and Plague Pathogens Pathogens May 28, 2019 …
Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994 Antimicrobial Resistance July 16, 2018 …
